HORMONE RECEPTOR POSITIVE TUMOR
Clinical trials for HORMONE RECEPTOR POSITIVE TUMOR explained in plain language.
Never miss a new study
Get alerted when new HORMONE RECEPTOR POSITIVE TUMOR trials appear
Sign up with your email to follow new studies for HORMONE RECEPTOR POSITIVE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radio wave device aims to shrink breast tumors before operation
Disease control Recruiting nowThis study is testing if a new device called TheraBionic P1 can help shrink tumors in people with early-stage breast cancer before they have surgery. The device uses specific radio waves aimed at cancer cells. Researchers will enroll 24 participants to see if adding this device t…
Matched conditions: HORMONE RECEPTOR POSITIVE TUMOR
Phase: NA • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New pill targets Tough-to-Treat cancers in early trial
Disease control Recruiting nowThis early-stage study is testing a new oral medication called INX-315 in people with advanced cancers that have spread or stopped responding to standard treatments. It aims to find a safe dose and see if the drug can help control cancers like certain types of breast and ovarian …
Matched conditions: HORMONE RECEPTOR POSITIVE TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Incyclix Bio • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Groundbreaking trial matches breast cancer drugs to your tumor
Disease control Recruiting nowThis trial aims to find the best drug combinations for different types of breast cancer before surgery. It tests new drugs alongside standard chemotherapy in 5,000 women with early-stage or locally advanced breast cancer. The study uses tumor analysis and MRI scans to match treat…
Matched conditions: HORMONE RECEPTOR POSITIVE TUMOR
Phase: PHASE2 • Sponsor: QuantumLeap Healthcare Collaborative • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
New hope for advanced breast cancer patients after standard treatment fails
Disease control Recruiting nowThis global Phase 3 trial is testing which of two drug combinations works better to control advanced breast cancer that has a specific genetic change (PIK3CA mutation) and has worsened after standard hormone therapy. It will enroll about 540 adults whose cancer has returned or sp…
Matched conditions: HORMONE RECEPTOR POSITIVE TUMOR
Phase: PHASE3 • Sponsor: Relay Therapeutics, Inc. • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC
-
Scientists probe why breast cancer patients skip their meds
Knowledge-focused Recruiting nowThis study aims to understand how consistently patients take their breast cancer medications. Researchers will compare two groups: those taking a standard hormone therapy pill versus those taking that pill plus an additional drug called abemaciclib. They will track 319 patients f…
Matched conditions: HORMONE RECEPTOR POSITIVE TUMOR
Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Apr 01, 2026 21:56 UTC